Investor Presentaiton

Annual price increase reporting: Data elements • The research and development costs associated with the prescription drug that were paid using public funds, including all available information about the sources and uses of these public funds . • . The total sales revenue for the prescription drug during the previous calendar year The manufacturer's net profit attributable to the prescription drug during the previous calendar year The introductory price of the prescription drug when it was approved for marketing by the United States Food and Drug Administration 19

View entire presentation